The focus of the “2014 AHA/ACC Guideline for the Management of Patients With Valvular
Heart Disease” 9, 10 (2014 VHD guideline) was the diagnosis and management of adult …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through November 2012, and other …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Bioprosthetic valve (BPV) thrombosis is considered a relatively rare clinical entity. Yet a
more recent analysis involving a more systematic echocardiographic follow-up, the advent of …

Background Prosthetic valve thrombosis (PVT) is one of the life-threatening complications of
prosthetic heart valve replacement. Due to the lack of randomized controlled trials, the …

Background Low-dose (25 mg), slow infusion (6 hours) of tissue-type plasminogen activator
(t-PA) with repetition as needed has been shown to provide effective and safer thrombolysis …

Background—Prosthetic valve thrombosis during pregnancy is life-threatening for mother
and fetus, and the treatment of this complication is unclear. Cardiac surgery in pregnancy is …

Background—Distinguishing pannus and thrombus in patients with prosthetic valve
dysfunction is essential for the selection of proper treatment. We have investigated the utility …

Valve thrombosis can occur in mechanical prosthetic valves and is increasingly recognised
in transcatheter and surgically implanted bioprosthetic valves. The risk of thrombosis of …